object
present
studi
conduct
evalu
activ
nanomet
propoli
flavon
npf
inhibit
porcin
parvoviru
ppv
vitro
vivo
method
vitro
effect
npf
cellular
infect
ppv
carri
ad
drug
simultan
ad
ppv
mix
vivo
antippv
effect
npf
guinea
pig
perform
result
result
show
npf
could
significantli
inhibit
ppv
infect
porcin
kidney
pk
cell
compar
propoli
flavon
pf
activ
npf
best
pread
drug
pattern
npf
high
medium
dose
abl
observ
restrain
ppv
copi
lung
gonad
blood
spleen
decreas
impact
ppv
weight
guinea
pig
improv
hemagglutin
inhibit
hi
ppv
serum
addit
could
also
increas
content
serum
ppv
challeng
conclus
result
indic
npf
could
significantli
improv
antippv
activ
pf
high
concentr
possess
best
efficaci
therefor
npf
would
expect
exploit
newstyl
antivir
drug
recent
year
anim
infecti
diseas
especi
viral
diseas
sever
acut
respiratori
syndrom
untyp
classic
swine
fever
swine
hyperpyrexia
diseas
newcastl
diseas
cow
transmiss
spongiform
encephalopathi
worldwid
concern
take
stage
comeback
spread
quickli
emerg
continu
constantli
caus
enorm
loss
domest
anim
porcin
parvoviru
ppv
character
member
autonom
parvovirus
one
main
pathogen
could
caus
reproduct
failur
pregnant
sow
character
fetal
embryon
death
stillbirth
mummif
delay
return
oestru
although
acut
infect
postnat
nonpregn
pig
often
subclin
ppv
link
interstiti
nephriti
slaughter
age
pig
skin
lesion
occurr
piglet
nonsuppur
myocard
lactat
piglet
recent
ppv
gain
attent
agent
abl
potenti
effect
porcin
circoviru
type
infect
clinic
cours
postwean
multisystem
wast
syndrom
worldwid
signific
econom
diseas
besid
associ
patholog
condit
abovement
clinic
vaccin
inactiv
ppv
gener
consid
offer
good
protect
ppv
use
control
reproduct
failur
due
ppv
sever
inactiv
aluminum
hydroxid
adjuv
vaccin
ppv
immunoprophylaxi
avail
unit
state
oil
emuls
adjuv
vaccin
ppv
licens
veterinari
drug
standard
peopl
republ
china
past
year
demonstr
mani
chines
herbal
medicin
chm
ingredi
chmi
possess
antivir
effect
vitro
vivo
chm
chmi
isatidi
radix
angelica
polysaccharid
astragalu
polysaccharid
isol
isati
indigotica
fort
angelica
sinensi
oliv
diel
astragalu
membranaceu
fisch
respect
develop
antivir
antibacteri
agent
one
hand
mani
research
demonstr
chm
chmi
contain
mani
antivir
activ
materi
mani
activ
materi
still
discov
hand
chm
chmi
possess
mani
biolog
activ
inhibit
viral
process
adsorpt
transcript
replic
releas
adjust
immunolog
function
antioxid
show
depend
biolog
function
light
side
effect
littl
toxic
moreov
new
viru
variant
strain
old
viru
aris
continu
antivir
drug
screen
chm
becam
hotspot
mani
investig
propoli
appli
empir
tradit
cure
folk
medicin
centuri
mixtur
form
honeybe
variou
plant
resin
mandibular
gland
secret
propoli
rich
biochem
constitu
compound
identifi
flavon
one
import
pharmacolog
activ
constitu
propoli
thought
respons
mani
biolog
pharmacolog
activ
well
known
valuabl
health
benefit
report
possess
reliabl
biolog
activ
includ
antiviru
immun
enhanc
antioxid
antibiosi
hepatoprotect
anticanc
antifatigu
excel
immun
system
booster
natur
antibiot
side
effect
recent
propoli
becom
issu
increas
interest
among
investig
owe
versatil
biolog
activ
due
biolog
activ
propoli
broadli
market
healthfood
altern
medicin
variou
part
world
propoli
flavon
pf
kind
ingredi
extract
propoli
harmless
natur
adjuv
antiviru
use
chicken
vaccin
activ
inactiv
vaccin
mani
studi
prove
pf
could
improv
immuneenhanc
activ
cellular
humor
immun
respons
addit
previou
studi
also
demonstr
adjuv
effect
featur
pf
inactiv
ppv
vaccin
guinea
pig
consid
success
cellular
humor
immun
previou
research
show
pf
possess
better
immun
enhanc
antippv
activ
present
studi
pf
process
nanomet
pf
npf
nanotechnolog
besid
author
determin
effect
npf
antippv
vitro
vivo
aim
studi
assess
antivir
effect
characterist
npf
compar
pf
cell
guinea
pig
respect
afford
theoret
evid
npf
develop
new
antivir
drug
scienc
veterinari
medicin
academi
shandong
provinc
ethyl
acet
purchas
basf
berlin
germani
ppv
tcid
cell
suppli
china
institut
veterinari
drug
control
dmem
gibco
supplement
iu
ml
streptomycin
iu
ml
benzylpenicillin
fetal
bovin
serum
use
resuspend
wash
cell
cultur
cell
dilut
mitogen
bromid
mtt
american
co
dissolv
calcium
magnesiumfre
phosphatebuff
salin
pb
ph
dimethyl
sulfoxid
produc
zhengx
chemic
co
ltd
suzhou
china
dimethyl
sulfoxid
dmso
product
chemic
reagent
ltd
shanghai
lingfeng
reagent
filter
millipor
membran
filter
enzymelink
immunosorb
assay
elisa
kit
ifn
purchas
r
system
inc
minneapoli
usa
ethyl
acet
ethanol
analyt
grade
suppli
kermel
chemic
co
ltd
tianjin
china
chemic
analyt
grade
flavon
base
consequ
preliminari
experi
npf
prepar
desir
compon
ratio
therefor
ethyl
acet
ethanol
deioniz
water
select
oili
phase
surfact
cosurfact
aqueou
phase
respect
besid
optim
ratio
surfact
cosurfact
instal
ww
first
pf
mix
compound
oil
surfact
cosurfact
certain
ratio
water
ad
compound
dropwis
agit
h
c
solut
filter
membran
averag
particl
size
zeta
potenti
npf
nm
mv
electron
microscop
npf
close
spheric
appear
diamet
npf
determin
transmiss
electron
microscopi
ideal
agreement
particl
size
determin
grew
monolay
plate
seri
concentr
npf
pf
ad
plate
six
well
concentr
cultur
h
c
humid
atmospher
co
l
mtt
ad
well
sequenti
incub
h
supernat
remov
l
dmso
ad
plate
shaken
min
dissolv
dmso
crystal
complet
well
absorb
nm
valu
determin
micro
liter
enzymelink
immunosorb
assay
reader
type
vacuum
tube
manufactur
east
china
valu
correl
live
cell
number
bigger
valu
live
cell
valu
npf
pf
group
significantli
lower
cell
control
group
indic
npf
pf
cytotox
correspond
concentr
consid
maxim
safeti
concentr
accord
result
safeti
concentr
five
npf
pf
concentr
select
measur
antivir
activ
mtt
method
realtim
fluoresc
quantit
evidencebas
complementari
altern
medicin
rtfq
pcr
cell
cultur
monolay
five
npf
pf
dilut
ppv
ad
cell
plate
respect
three
pattern
ad
npf
pf
firstli
npf
pf
solut
ad
cell
plate
lwell
six
well
per
concentr
incub
h
c
co
npf
pf
solut
remov
cell
wash
twice
hank
solut
ppv
solut
ad
ad
npf
pf
firstli
ppv
solut
ad
cell
plate
incub
h
ppv
solut
remov
cell
wash
twice
hank
solut
npf
pf
solut
ad
six
well
concentr
mix
ad
npf
pf
ppv
npf
pf
solut
concentr
mix
ppv
solut
incub
h
c
ad
cell
plate
six
well
concentr
cell
plate
place
co
incub
c
ppv
control
group
show
markedli
cytopath
effect
cpe
h
cell
viabil
determin
mtt
assay
ppv
content
cell
determin
rtfq
pcr
mean
cellular
valu
viru
content
use
indic
antivir
activ
valu
npf
pf
group
significantli
higher
ppv
control
group
viru
content
npf
pf
group
significantli
lower
ppv
control
group
indic
correspond
npf
pf
signific
antivir
activ
britain
white
guinea
pig
fourmonthold
equal
male
femal
purchas
experiment
anim
center
chines
medicin
beij
china
guinea
pig
rais
cm
cm
cm
wire
cage
cage
aircondit
room
c
illumin
h
receiv
water
feed
ad
libitum
hemagglutin
inhibit
hi
antibodi
ppv
guinea
pig
zero
experi
experi
guinea
pig
divid
group
randomli
guinea
pig
six
drug
group
intragastr
administr
respect
high
middl
low
dose
npf
pf
challeng
control
cc
blank
control
bc
group
dose
physiolog
salin
continu
three
day
day
intragastr
administr
guinea
pig
six
group
cc
group
challeng
ml
ppv
challeng
dosag
log
titer
median
tissu
cultur
infect
dose
tcid
ml
day
challeng
blood
sampl
hi
serum
antibodi
titer
analysi
micromethod
content
ifn
elisa
ppv
content
tissu
lung
gonad
spleen
liver
blood
measur
method
rtfq
pcr
weight
guinea
pig
group
also
observ
day
challeng
titr
ppv
determin
blood
sampl
ml
per
guinea
pig
ear
vein
drawn
eppendorf
tube
place
clot
c
h
serum
separ
measur
hi
antibodi
centrifug
briefli
twofold
serial
dilut
l
serum
ad
vshape
bottom
microtit
plate
contain
l
cmfpb
well
inactiv
c
min
l
ppv
antigen
ha
unit
join
well
except
last
row
serv
control
serum
dilut
rang
join
vshape
bottom
microtit
plate
serumantigen
mixtur
incub
c
min
microlitr
rooster
erythrocyt
suspens
join
well
reincub
c
min
neg
serum
posit
serum
antigen
erythrocyt
also
includ
highest
serum
dilut
caus
complet
inhibit
regard
endpoint
geometr
mean
titer
mark
reciproc
log
valu
highest
hi
antibodi
titer
dilut
serum
concentr
cytokin
includ
ifn
determin
elisa
accord
instruct
manufactur
briefli
captur
antibodi
specif
cytokin
coat
flat
bottom
microtit
plate
nunc
usa
l
serial
dilut
specif
standard
serum
ad
respect
well
plate
wash
block
captur
cytokin
detect
mean
specif
conjug
detect
antibodi
seri
wash
substrat
reagent
attend
well
color
chang
plate
count
nm
use
elisa
reader
biotek
instrument
inc
cytokin
concentr
accomplish
standard
curv
plot
valu
dilut
standard
concentr
determin
viral
genom
dna
extract
tissu
challeng
guinea
pig
use
rnadna
extract
kit
ver
takara
dalian
china
accord
protocol
manufactur
seri
test
perform
optim
rtfr
pcr
protocol
includ
pcr
cycl
paramet
reagent
concentr
optim
singleplex
realtim
pcr
assay
ppv
essenti
subsequ
pcr
reaction
water
instead
templat
dna
use
neg
control
use
run
test
rtfr
pcr
reaction
perform
triplic
total
tissu
serum
sampl
test
ppv
rtfr
pcr
convent
pcr
assay
convent
rtfr
pcr
assay
condit
standard
plasmid
templat
prepar
describ
analysi
data
shown
mean
sd
lsd
duncan
multipl
rang
test
use
tabl
npf
group
cell
valu
group
observ
lower
cell
control
group
maxim
safeti
concentr
could
ascertain
np
group
cell
valu
group
significantli
lower
cell
control
group
maxim
safeti
concentr
could
determin
order
observ
action
level
npf
pf
maxim
safeti
concentr
suppos
cytoact
cell
challeng
ppv
shown
figur
ad
pattern
cell
challeng
ppv
content
cell
challeng
illustr
figur
pread
pattern
concentr
ppv
content
cell
npf
pf
group
significantli
lower
ppv
control
npf
group
observ
lower
pf
group
postad
pattern
ppv
content
cell
npf
pf
concentr
group
markedli
lower
ppv
control
npf
group
observ
lower
pf
group
simultan
ad
pattern
ppv
content
cell
npf
pf
concentr
group
significantli
lower
ppv
control
npf
day
ppv
challeng
ppv
content
gonad
day
ppv
challeng
ppv
content
blood
group
observ
lower
pf
group
blood
dynam
chang
ppv
content
everi
group
lung
gonad
blood
shown
figur
b
c
respect
day
challeng
ppv
content
cc
group
lung
gonad
blood
highest
observ
higher
npf
pf
group
day
challeng
lung
gonad
blood
ppv
content
npf
pf
group
significantli
lower
cc
group
high
middl
dose
high
middl
dose
lung
gonad
blood
ppv
content
npf
group
markedli
lower
pf
group
liver
dynam
chang
ppv
content
everi
group
spleen
liver
illustr
figur
b
respect
day
challeng
spleen
ppv
content
npf
pf
group
observ
lower
cc
group
high
middl
dose
day
spleen
ppv
content
npf
significantli
lower
pf
group
high
middl
dose
ppv
content
liver
low
challeng
day
liver
ppv
content
npf
pf
group
significantli
lower
cc
group
high
middl
dose
result
shown
figur
hi
antibodi
titer
ppv
npf
pf
group
significantli
lower
cc
group
high
middl
dose
day
challeng
day
hi
antibodi
titer
ppv
npf
observ
higher
pf
group
high
dose
day
challeng
hi
antibodi
titer
ppv
npf
markedli
higher
pf
group
high
middl
dose
variat
content
everi
group
serum
illustr
figur
challeng
serum
content
chang
npf
pf
group
observ
higher
cc
group
high
middl
dose
day
challeng
significantli
higher
cc
group
high
dose
day
challeng
serum
content
chang
npf
group
markedli
higher
pf
group
high
middl
dose
variat
content
everi
group
serum
illustr
figur
b
day
challeng
serum
content
chang
npf
group
observ
higher
cc
group
high
middl
dose
day
challeng
serum
content
chang
pf
group
significantli
higher
cc
group
high
middl
dose
day
challeng
markedli
higher
cc
group
high
dose
day
challeng
serum
content
chang
npf
group
significantli
higher
pf
group
high
dose
day
challeng
observ
higher
pf
group
high
middl
dose
variat
ifn
content
everi
group
serum
illustr
figur
c
day
challeng
serum
ifn
content
chang
npf
group
markedli
higher
cc
group
high
middl
dose
day
challeng
significantli
higher
cc
group
high
dose
day
challeng
serum
ifn
content
chang
pf
group
observ
higher
cc
group
high
middl
dose
day
challeng
serum
ifn
content
chang
npf
group
significantli
higher
pf
group
high
middl
dose
chang
weight
everi
group
shown
figur
day
challeng
chang
weight
npf
group
observ
higher
cc
group
high
dose
day
challeng
significantli
higher
cc
group
high
middl
dose
day
challeng
chang
weight
pf
group
significantli
higher
cc
group
high
dose
day
challeng
chang
weight
npf
group
markedli
higher
pf
group
high
middl
dose
mtt
method
one
kind
method
detect
surviv
growth
cell
detect
principl
exogen
mtt
could
reduc
water
therefor
larger
valu
live
cell
experi
vitro
design
three
drugad
pattern
respect
correspond
prevent
steril
treatment
three
clinic
administr
present
experi
valu
npf
concentr
significantli
higher
pf
viru
control
group
three
ad
mode
result
suggest
npf
could
effect
inhibit
ppv
infect
cell
vitro
prevent
effect
better
steril
treatment
reason
may
particl
size
npf
small
quit
homogen
advantag
penetr
cell
membran
absorb
cell
npf
enter
organ
deceler
drug
releas
lengthen
action
time
drug
organ
prevent
drug
degrad
rapidli
mani
research
vivo
also
confirm
efficaci
drug
nanocrystal
significantli
better
convent
drug
consist
experiment
result
viru
content
infecti
cell
also
indic
antivir
effect
drug
test
content
ppv
cell
group
npf
pf
observ
lower
correspond
viru
control
group
three
mode
addit
content
ppv
cell
group
npf
markedli
fewer
correspond
pf
group
three
ad
drug
pattern
proper
concentr
result
indic
npf
could
effect
inhibit
ppv
replic
cell
pf
clinic
sampl
ppv
infecti
pig
ppv
often
detect
tissu
lymph
node
lung
guinea
pig
model
anim
discuss
immun
immun
respons
ppv
vaccin
experi
vivo
ppv
content
tissu
lung
gonad
spleen
liver
blood
measur
challeng
ppv
mainli
propag
gonad
lung
blood
high
middl
dose
ppv
content
npf
group
significantli
lower
correspond
pf
cc
group
tissu
lung
gonad
spleen
blood
result
suggest
npf
could
effect
inhibit
ppv
infect
tissu
lung
gonad
gonad
key
organ
ppv
replic
npf
could
significantli
restrain
ppv
infect
gonad
npf
abl
effect
allevi
ppv
reproduct
failur
reduc
econom
loss
clinic
c
c
ab
ab
c
c
c
c
b
b
c
c
c
c
b
b
result
vivo
test
reveal
earli
period
ppv
challeng
hi
antibodi
titer
serum
npf
group
higher
pf
cc
group
indic
npf
superior
pf
produc
antibodi
could
make
challeng
anim
effect
resist
viru
infect
fan
et
al
also
confirm
pf
design
microemuls
abl
significantli
increas
thymu
spleen
indic
enhanc
content
igm
igg
serum
igm
play
import
role
initi
stage
antiinfect
immun
origin
produc
first
humor
immun
respons
igg
possess
high
content
long
durat
primari
antibodi
antiinfect
immun
present
experi
concentr
ifn
serum
determin
concentr
ifn
npf
group
higher
pf
cc
group
earli
stage
concentr
npf
group
higher
pf
cc
group
later
period
high
middl
dose
cytokin
secret
type
helper
cell
cell
abl
mediat
cellular
immun
also
abl
promot
product
immunoglobulin
stimul
prolifer
differenti
natur
killer
cell
indispens
tcell
immunolog
memori
secret
type
helper
cell
cell
abl
coordin
humor
immun
cytokin
frequent
use
detect
antigen
specif
cell
ifn
also
secret
cell
reflect
basic
statu
cellular
immun
humor
immun
organ
certain
extent
level
cytokin
secret
antibodi
titer
respect
reflect
state
cellular
immun
humor
immun
anim
organ
fischer
et
al
report
cellular
humor
immun
play
import
role
defens
infecti
diseas
host
present
research
demonstr
npf
could
improv
cellular
humor
immun
thu
abl
protect
guinea
pig
attack
ppv
abil
modul
synthesi
antibodi
cytokin
secret
part
npf
activ
compar
pf
despit
fact
precis
action
mechan
npf
immun
system
remain
unknown
probabl
amplif
immun
cell
reaction
one
main
antivir
mechan
weight
import
indic
reflect
situat
organ
diseas
previou
research
confirm
pf
chmi
could
effect
allevi
harm
caus
viru
increas
weight
challeng
anim
result
present
studi
also
demonstr
weight
npf
high
medium
dose
group
significantli
higher
pf
cc
group
later
period
weight
npf
high
group
significantli
lower
bc
group
indic
nanotechnolog
could
remark
enhanc
antivir
activ
pf
studi
assess
antiporcin
parvoviru
activ
npf
pf
vitro
vivo
vitro
npf
could
significantli
inhibit
ppv
infect
cell
compar
pf
prevent
effect
better
steril
treatment
vivo
npf
abl
observ
restrain
ppv
copi
lung
gonad
blood
lessen
impact
ppv
weight
guinea
pig
increas
hemagglutin
inhibit
ppv
serum
could
also
improv
content
ifn
serum
challeng
therefor
nanotechnolog
could
observ
enhanc
antippv
activ
pf
studi
safeti
stabil
mechan
action
npf
need
pursu
potenti
clinic
applic
antivir
drug
